Omnicell Cash And Short Term Investments vs Current Deferred Revenue Analysis
OMCL Stock | USD 30.44 1.22 3.85% |
Omnicell financial indicator trend analysis is much more than just breaking down Omnicell prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Omnicell is a good investment. Please check the relationship between Omnicell Cash And Short Term Investments and its Current Deferred Revenue accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omnicell. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Omnicell Stock please use our How to buy in Omnicell Stock guide.
Cash And Short Term Investments vs Current Deferred Revenue
Cash And Short Term Investments vs Current Deferred Revenue Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Omnicell Cash And Short Term Investments account and Current Deferred Revenue. At this time, the significance of the direction appears to have strong relationship.
The correlation between Omnicell's Cash And Short Term Investments and Current Deferred Revenue is 0.75. Overlapping area represents the amount of variation of Cash And Short Term Investments that can explain the historical movement of Current Deferred Revenue in the same time period over historical financial statements of Omnicell, assuming nothing else is changed. The correlation between historical values of Omnicell's Cash And Short Term Investments and Current Deferred Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash And Short Term Investments of Omnicell are associated (or correlated) with its Current Deferred Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Deferred Revenue has no effect on the direction of Cash And Short Term Investments i.e., Omnicell's Cash And Short Term Investments and Current Deferred Revenue go up and down completely randomly.
Correlation Coefficient | 0.75 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Cash And Short Term Investments
Short Term Investments is an account in the current assets section of Omnicell balance sheet. This account contains Omnicell investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Omnicell fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.Current Deferred Revenue
Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.Most indicators from Omnicell's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Omnicell current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omnicell. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Omnicell Stock please use our How to buy in Omnicell Stock guide.At this time, Omnicell's Selling General Administrative is quite stable compared to the past year. Enterprise Value Over EBITDA is expected to rise to 34.21 this year, although the value of Tax Provision will most likely fall to (2.8 M).
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 554.7M | 589.0M | 496.8M | 521.7M | Total Revenue | 1.1B | 1.3B | 1.1B | 1.2B |
Omnicell fundamental ratios Correlations
Click cells to compare fundamentals
Omnicell Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Omnicell fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 1.2B | 1.8B | 2.1B | 2.2B | 2.2B | 2.3B | |
Short Long Term Debt Total | 100.7M | 516.1M | 528.1M | 616.7M | 614.1M | 644.8M | |
Other Current Liab | 89.7M | 123.9M | 204.3M | 235.3M | 180.0M | 189.0M | |
Total Current Liabilities | 237.0M | 276.4M | 876.2M | 428.4M | 367.8M | 386.2M | |
Total Stockholder Equity | 845.3M | 967.5M | 1.1B | 1.1B | 1.2B | 1.2B | |
Other Liab | 57.9M | 64.5M | 79.7M | 46.2M | 53.1M | 33.7M | |
Property Plant And Equipment Net | 110.4M | 114.2M | 119.7M | 132.0M | 133.6M | 140.3M | |
Current Deferred Revenue | 90.9M | 100.1M | 112.2M | 118.9M | 132.3M | 138.9M | |
Net Debt | (26.5M) | 30.2M | 179.0M | 286.4M | 113.1M | 118.8M | |
Retained Earnings | 258.8M | 290.7M | 368.6M | 390.7M | 370.4M | 388.9M | |
Accounts Payable | 46.4M | 40.3M | 71.5M | 63.4M | 45.0M | 25.0M | |
Cash | 127.2M | 485.9M | 349.1M | 330.4M | 501.0M | 526.0M | |
Non Current Assets Total | 757.6M | 995.1M | 1.4B | 1.3B | 1.3B | 1.4B | |
Non Currrent Assets Other | 151.9M | 176.2M | 191.3M | 164.5M | 64.4M | 52.5M | |
Long Term Debt | 135.4M | 50M | 467.2M | 566.6M | 569.7M | 598.1M | |
Cash And Short Term Investments | 127.2M | 485.9M | 349.1M | 330.4M | 501.0M | 526.0M | |
Net Receivables | 218.4M | 190.1M | 240.9M | 299.5M | 263.9M | 277.1M | |
Common Stock Total Equity | 51K | 53K | 54K | 55K | 49.5K | 47.0K | |
Common Stock Shares Outstanding | 42.9M | 43.7M | 47.9M | 45.9M | 45.2M | 36.4M | |
Liabilities And Stockholders Equity | 1.2B | 1.8B | 2.1B | 2.2B | 2.2B | 2.3B | |
Non Current Liabilities Total | 158.6M | 580.6M | 119.6M | 652.2M | 670.1M | 703.6M | |
Inventory | 108.0M | 96.3M | 119.9M | 147.5M | 110.1M | 115.6M | |
Other Current Assets | 15.2M | 41.0M | 48.3M | 77.4M | 52.6M | 55.2M | |
Other Stockholder Equity | 595.9M | 682.3M | 786.5M | 756.4M | 832.0M | 873.6M | |
Total Liab | 395.6M | 857.0M | 995.8M | 1.1B | 1.0B | 1.1B | |
Property Plant And Equipment Gross | 110.4M | 114.2M | 119.7M | 132.0M | 273.0M | 286.7M | |
Total Current Assets | 483.2M | 829.4M | 780.7M | 881.8M | 927.6M | 973.9M | |
Accumulated Other Comprehensive Income | (9.4M) | (5.5M) | (8.4M) | (17.1M) | (13.4M) | (14.1M) | |
Short Term Debt | 10.1M | 12.2M | 488.2M | 10.8M | 10.5M | 10.0M | |
Common Stock | 51K | 53K | 54K | 55K | 56K | 53.2K | |
Property Plant Equipment | 54.2M | 59.1M | 119.7M | 94.0M | 108.1M | 113.5M | |
Other Assets | 100.7M | 268.5M | 225.6M | 139.0M | 159.8M | 167.8M | |
Good Will | 336.5M | 499.3M | 738.9M | 734.3M | 735.8M | 772.6M | |
Intangible Assets | 124.9M | 168.2M | 277.6M | 242.9M | 277.8M | 291.7M | |
Net Tangible Assets | 845.3M | 967.5M | 130.2M | 153.0M | 175.9M | 297.7M | |
Retained Earnings Total Equity | 258.8M | 290.7M | 368.6M | 390.7M | 449.3M | 471.8M | |
Capital Surpluse | 780.9M | 920.4M | 1.0B | 1.0B | 1.2B | 729.3M | |
Deferred Long Term Liab | 39.1M | 4.3M | 51.7M | 2.1M | 1.9M | 1.8M |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Omnicell using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omnicell. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Omnicell Stock please use our How to buy in Omnicell Stock guide.Note that the Omnicell information on this page should be used as a complementary analysis to other Omnicell's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Complementary Tools for Omnicell Stock analysis
When running Omnicell's price analysis, check to measure Omnicell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Omnicell is operating at the current time. Most of Omnicell's value examination focuses on studying past and present price action to predict the probability of Omnicell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Omnicell's price. Additionally, you may evaluate how the addition of Omnicell to your portfolios can decrease your overall portfolio volatility.
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |
Is Omnicell's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omnicell. If investors know Omnicell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omnicell listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.68) | Earnings Share (0.46) | Revenue Per Share 24.275 | Quarterly Revenue Growth (0.15) | Return On Assets (0.01) |
The market value of Omnicell is measured differently than its book value, which is the value of Omnicell that is recorded on the company's balance sheet. Investors also form their own opinion of Omnicell's value that differs from its market value or its book value, called intrinsic value, which is Omnicell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omnicell's market value can be influenced by many factors that don't directly affect Omnicell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Omnicell's value and its price as these two are different measures arrived at by different means. Investors typically determine if Omnicell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omnicell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.